Key Product Details

Species Reactivity

Validated:

Human

Cited:

Human, Transgenic Mouse

Applications

Validated:

Western Blot

Cited:

Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot, Immunoprecipitation, Electrochemiluminescent Assay, ELISA Development

Label

Unconjugated

Antibody Source

Polyclonal Goat IgG
View all IL-32 Primary Antibodies »

Product Specifications

Immunogen

E. coli-derived recombinant human IL‑32 alpha
Cys2-Lys131
Accession # NP_001012651

Specificity

Detects human IL-32 in direct ELISAs and Western blots.

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Scientific Data Images for Human IL-32 Antibody

Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

IL-32 is stabilized by deubiquitinases. (A) JJN3 cells were stimulated with PR619 (30 μM during normoxia and hypoxia before the sample was harvested at indicated time points. The figure shows representative WB of IL-32 protein levels of n = 3 independent experiments. (B) JJN3 cells were incubated overnight in hypoxia before they were moved to normoxia for 4 h with and without PR619 stimulation. Cells were harvested, and lysates were processed in the presence of a NEM-DUB inhibitor. Ubiqutinylated and nonubiqutinylated 27 kDA IL-32 proteins were assessed by WB. (C) JJN3 cells were stimulated with a panel of DUB inhibitors (see Supplementary Table S1 for concentrations) for 4 h, and IL-32 protein levels were analyzed by WB. Shown here is the representative WB of n = 3 independent experiments. (D) Human primary T cells isolated from healthy blood donors were treated with CHX (5 µg/ml), MG132 (20 µM), and PR619 (30 µM) and harvested at the indicated time points. Shown here is the representative WB from experiments with n = 3 donors. (E) Human primary T cells isolated from healthy blood donors were cultured overnight in hypoxia before IL-32 protein levels were assessed by WB. A representative WB from experiments with three different donors is shown here. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

IL-32 protein half-life is regulated by the oxygen sensor ADO. (A) JJN-3 cells were transfected with ADO- and nontargeting Ctrl siRNA. After 24 h, the cells were seeded and cultured overnight in normoxia or hypoxia before being treated with 5 μg/ml CHX and the IL-32 CHX chase assay in normoxia and hypoxia. One representative WB of IL-32 and ADO siRNA-treated cells of n = 5 independent experiments is shown. (B) JJN-3 cells were transfected with ADO and nontargeting Ctrl siRNA. After being transfected for 24 h, the cells were cultured overnight in hypoxia before being treated with 5 µg/ml CHX and reoxygenized in normoxic culture conditions. Cells were harvested at indicated time points. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

TLR-induced NF kappa B signaling promotes IL-32 expression in MM cells. (A) RPMI-8226 cells were stimulated with TLR agonists (for concentrations, see methods) for 4 and 24 hours and IL-32 mRNA expression was assessed by qPCR. The figure shows mean ± SEM of 3 independent experiments. (B) RPMI-8226 cells were stimulated with TLR agonists for 4 and 24 hours and IL-32 protein expression was evaluated by western blot. The figure shows representative western blot of 3 independent experiments. (C) RPMI-8226 cells were harvested at different time-points following LPS stimulation (0.1 µg/mL) and IL-32 mRNA expression was analyzed by qPCR (mean ± SD) and (D) IL-32 protein expression by western blot (E) RPMI-8226 TLR4 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. Figure shows representative western blot (n=3) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (F) RPMI-8226 TLR9 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. The figure shows representative western blot (n=2) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (G) RPMI-8226 cells were stimulated with LPS (0.1 µg/mL) and NG25 (2 µM) or IKK VII (10 µM) for 4 hours. IL-32 mRNA expression (mean ± SEM, n=3) was assessed by qPCR. (H) RPMI-8226 cells were stimulated with LPS, NG25 and IKK VII (concentrations as above) for 4 hours. The figure shows representative western blot (n=3) of IL-32 protein expression. P-values in (A) and (G) are calculated by one-way ANOVA with Dunnett´s multiple comparison test. *p≤ 0.05, **p ≤ 0.001, ****p ≤ 0.0001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36875074), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Human IL-32 by Western Blot

Detection of Human IL-32 by Western Blot

IL-32 is degraded through the ubiquitin-proteasome pathway. (A, B) JJN3 cells were treated with 20 µM MG-132 and harvested at the indicated time points. IL-32 protein levels were analyzed by (A) Western blotting, and (B) IL-32 mRNA was assessed by qPCR using GAPDH as housekeeping gene. The bars show the mean RQ of IL-32 ± SD. (C) Confocal images of JJN3 cells treated for 4 h with 100 nM carfilzomib and stained with IL-32 antibody (green) and Hoechst (blue). (D) JJN3 cells were transfected with HA-ubiquitin plasmid and incubated in hypoxia overnight before the cells were harvested and IL-32 immunoprecipitation was performed. Protein levels of HA-ubiquitin, IL-32, and GAPDH loading control were evaluated on WB. Total lysate and IP samples from the same membrane are shown with different brightness/contrast. (E) JJN3 cells were incubated overnight in hypoxia before they were stimulated with MG-132 for 4 h and harvested for TUBE assay of ubiquitinylated proteins. The presence of IL-32 and ubiquitin protein in TUBE pulldown was assessed by WB. DUB treatment for reversal of polyubiqutinylation was included to validate ubiquitin/TUBE pulldown. Total lysate and TUBE samples from the same membrane are shown with different brightness/contrast. (F) JJN3 cells were stimulated with 2 μM TAK234 before the cells were harvested, and IL-32 levels were analyzed by WB. (A–F) One representative experiment out of three is shown. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

IL-32 protein half-life is regulated by the oxygen sensor ADO. (A) JJN-3 cells were transfected with ADO- and nontargeting Ctrl siRNA. After 24 h, the cells were seeded and cultured overnight in normoxia or hypoxia before being treated with 5 μg/ml CHX and the IL-32 CHX chase assay in normoxia and hypoxia. One representative WB of IL-32 and ADO siRNA-treated cells of n = 5 independent experiments is shown. (B) JJN-3 cells were transfected with ADO and nontargeting Ctrl siRNA. After being transfected for 24 h, the cells were cultured overnight in hypoxia before being treated with 5 µg/ml CHX and reoxygenized in normoxic culture conditions. Cells were harvested at indicated time points. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

IL-32 is stabilized by deubiquitinases. (A) JJN3 cells were stimulated with PR619 (30 μM during normoxia and hypoxia before the sample was harvested at indicated time points. The figure shows representative WB of IL-32 protein levels of n = 3 independent experiments. (B) JJN3 cells were incubated overnight in hypoxia before they were moved to normoxia for 4 h with and without PR619 stimulation. Cells were harvested, and lysates were processed in the presence of a NEM-DUB inhibitor. Ubiqutinylated and nonubiqutinylated 27 kDA IL-32 proteins were assessed by WB. (C) JJN3 cells were stimulated with a panel of DUB inhibitors (see Supplementary Table S1 for concentrations) for 4 h, and IL-32 protein levels were analyzed by WB. Shown here is the representative WB of n = 3 independent experiments. (D) Human primary T cells isolated from healthy blood donors were treated with CHX (5 µg/ml), MG132 (20 µM), and PR619 (30 µM) and harvested at the indicated time points. Shown here is the representative WB from experiments with n = 3 donors. (E) Human primary T cells isolated from healthy blood donors were cultured overnight in hypoxia before IL-32 protein levels were assessed by WB. A representative WB from experiments with three different donors is shown here. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Human IL-32 by Western Blot

Detection of Human IL-32 by Western Blot

IL-32 is degraded through the ubiquitin-proteasome pathway. (A, B) JJN3 cells were treated with 20 µM MG-132 and harvested at the indicated time points. IL-32 protein levels were analyzed by (A) Western blotting, and (B) IL-32 mRNA was assessed by qPCR using GAPDH as housekeeping gene. The bars show the mean RQ of IL-32 ± SD. (C) Confocal images of JJN3 cells treated for 4 h with 100 nM carfilzomib and stained with IL-32 antibody (green) and Hoechst (blue). (D) JJN3 cells were transfected with HA-ubiquitin plasmid and incubated in hypoxia overnight before the cells were harvested and IL-32 immunoprecipitation was performed. Protein levels of HA-ubiquitin, IL-32, and GAPDH loading control were evaluated on WB. Total lysate and IP samples from the same membrane are shown with different brightness/contrast. (E) JJN3 cells were incubated overnight in hypoxia before they were stimulated with MG-132 for 4 h and harvested for TUBE assay of ubiquitinylated proteins. The presence of IL-32 and ubiquitin protein in TUBE pulldown was assessed by WB. DUB treatment for reversal of polyubiqutinylation was included to validate ubiquitin/TUBE pulldown. Total lysate and TUBE samples from the same membrane are shown with different brightness/contrast. (F) JJN3 cells were stimulated with 2 μM TAK234 before the cells were harvested, and IL-32 levels were analyzed by WB. (A–F) One representative experiment out of three is shown. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Human IL-32 by Western Blot

Detection of Human IL-32 by Western Blot

IL-32 is degraded through the ubiquitin-proteasome pathway. (A, B) JJN3 cells were treated with 20 µM MG-132 and harvested at the indicated time points. IL-32 protein levels were analyzed by (A) Western blotting, and (B) IL-32 mRNA was assessed by qPCR using GAPDH as housekeeping gene. The bars show the mean RQ of IL-32 ± SD. (C) Confocal images of JJN3 cells treated for 4 h with 100 nM carfilzomib and stained with IL-32 antibody (green) and Hoechst (blue). (D) JJN3 cells were transfected with HA-ubiquitin plasmid and incubated in hypoxia overnight before the cells were harvested and IL-32 immunoprecipitation was performed. Protein levels of HA-ubiquitin, IL-32, and GAPDH loading control were evaluated on WB. Total lysate and IP samples from the same membrane are shown with different brightness/contrast. (E) JJN3 cells were incubated overnight in hypoxia before they were stimulated with MG-132 for 4 h and harvested for TUBE assay of ubiquitinylated proteins. The presence of IL-32 and ubiquitin protein in TUBE pulldown was assessed by WB. DUB treatment for reversal of polyubiqutinylation was included to validate ubiquitin/TUBE pulldown. Total lysate and TUBE samples from the same membrane are shown with different brightness/contrast. (F) JJN3 cells were stimulated with 2 μM TAK234 before the cells were harvested, and IL-32 levels were analyzed by WB. (A–F) One representative experiment out of three is shown. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

IL-32 is stabilized by deubiquitinases. (A) JJN3 cells were stimulated with PR619 (30 μM during normoxia and hypoxia before the sample was harvested at indicated time points. The figure shows representative WB of IL-32 protein levels of n = 3 independent experiments. (B) JJN3 cells were incubated overnight in hypoxia before they were moved to normoxia for 4 h with and without PR619 stimulation. Cells were harvested, and lysates were processed in the presence of a NEM-DUB inhibitor. Ubiqutinylated and nonubiqutinylated 27 kDA IL-32 proteins were assessed by WB. (C) JJN3 cells were stimulated with a panel of DUB inhibitors (see Supplementary Table S1 for concentrations) for 4 h, and IL-32 protein levels were analyzed by WB. Shown here is the representative WB of n = 3 independent experiments. (D) Human primary T cells isolated from healthy blood donors were treated with CHX (5 µg/ml), MG132 (20 µM), and PR619 (30 µM) and harvested at the indicated time points. Shown here is the representative WB from experiments with n = 3 donors. (E) Human primary T cells isolated from healthy blood donors were cultured overnight in hypoxia before IL-32 protein levels were assessed by WB. A representative WB from experiments with three different donors is shown here. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

TLR-induced NF kappa B signaling promotes IL-32 expression in MM cells. (A) RPMI-8226 cells were stimulated with TLR agonists (for concentrations, see methods) for 4 and 24 hours and IL-32 mRNA expression was assessed by qPCR. The figure shows mean ± SEM of 3 independent experiments. (B) RPMI-8226 cells were stimulated with TLR agonists for 4 and 24 hours and IL-32 protein expression was evaluated by western blot. The figure shows representative western blot of 3 independent experiments. (C) RPMI-8226 cells were harvested at different time-points following LPS stimulation (0.1 µg/mL) and IL-32 mRNA expression was analyzed by qPCR (mean ± SD) and (D) IL-32 protein expression by western blot (E) RPMI-8226 TLR4 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. Figure shows representative western blot (n=3) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (F) RPMI-8226 TLR9 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. The figure shows representative western blot (n=2) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (G) RPMI-8226 cells were stimulated with LPS (0.1 µg/mL) and NG25 (2 µM) or IKK VII (10 µM) for 4 hours. IL-32 mRNA expression (mean ± SEM, n=3) was assessed by qPCR. (H) RPMI-8226 cells were stimulated with LPS, NG25 and IKK VII (concentrations as above) for 4 hours. The figure shows representative western blot (n=3) of IL-32 protein expression. P-values in (A) and (G) are calculated by one-way ANOVA with Dunnett´s multiple comparison test. *p≤ 0.05, **p ≤ 0.001, ****p ≤ 0.0001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36875074), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

IL-32 has a high protein turnover. (A) JJN-3 cells were treated with CHX and harvested at the indicated time points. IL-32 protein levels were analyzed by WB. (B) Kinetics of IL-32 degradation in JJN3- cells. IL-32 protein signal intensity was quantified and normalized to loading control in n = 6 CHX chase experiments. The mean ±SEM is shown here. (C) JJN-3 cells were treated with 5 μg/ml CHX and 20 μM MG132 alone and in combination and harvested at the indicated time points. The figure shows one representative WB from n = 3 independent experiments. (D) Signal intensities of IL-32 and beta -actin were quantified from n = 3 independent experiments performed as in (C), and the values from treated samples at each time point were normalized relative to the control sample. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

TLR-induced NF kappa B signaling promotes IL-32 expression in MM cells. (A) RPMI-8226 cells were stimulated with TLR agonists (for concentrations, see methods) for 4 and 24 hours and IL-32 mRNA expression was assessed by qPCR. The figure shows mean ± SEM of 3 independent experiments. (B) RPMI-8226 cells were stimulated with TLR agonists for 4 and 24 hours and IL-32 protein expression was evaluated by western blot. The figure shows representative western blot of 3 independent experiments. (C) RPMI-8226 cells were harvested at different time-points following LPS stimulation (0.1 µg/mL) and IL-32 mRNA expression was analyzed by qPCR (mean ± SD) and (D) IL-32 protein expression by western blot (E) RPMI-8226 TLR4 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. Figure shows representative western blot (n=3) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (F) RPMI-8226 TLR9 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. The figure shows representative western blot (n=2) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (G) RPMI-8226 cells were stimulated with LPS (0.1 µg/mL) and NG25 (2 µM) or IKK VII (10 µM) for 4 hours. IL-32 mRNA expression (mean ± SEM, n=3) was assessed by qPCR. (H) RPMI-8226 cells were stimulated with LPS, NG25 and IKK VII (concentrations as above) for 4 hours. The figure shows representative western blot (n=3) of IL-32 protein expression. P-values in (A) and (G) are calculated by one-way ANOVA with Dunnett´s multiple comparison test. *p≤ 0.05, **p ≤ 0.001, ****p ≤ 0.0001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36875074), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

TLR-induced NF kappa B signaling promotes IL-32 expression in MM cells. (A) RPMI-8226 cells were stimulated with TLR agonists (for concentrations, see methods) for 4 and 24 hours and IL-32 mRNA expression was assessed by qPCR. The figure shows mean ± SEM of 3 independent experiments. (B) RPMI-8226 cells were stimulated with TLR agonists for 4 and 24 hours and IL-32 protein expression was evaluated by western blot. The figure shows representative western blot of 3 independent experiments. (C) RPMI-8226 cells were harvested at different time-points following LPS stimulation (0.1 µg/mL) and IL-32 mRNA expression was analyzed by qPCR (mean ± SD) and (D) IL-32 protein expression by western blot (E) RPMI-8226 TLR4 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. Figure shows representative western blot (n=3) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (F) RPMI-8226 TLR9 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. The figure shows representative western blot (n=2) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (G) RPMI-8226 cells were stimulated with LPS (0.1 µg/mL) and NG25 (2 µM) or IKK VII (10 µM) for 4 hours. IL-32 mRNA expression (mean ± SEM, n=3) was assessed by qPCR. (H) RPMI-8226 cells were stimulated with LPS, NG25 and IKK VII (concentrations as above) for 4 hours. The figure shows representative western blot (n=3) of IL-32 protein expression. P-values in (A) and (G) are calculated by one-way ANOVA with Dunnett´s multiple comparison test. *p≤ 0.05, **p ≤ 0.001, ****p ≤ 0.0001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36875074), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

IL-32 is stabilized by deubiquitinases. (A) JJN3 cells were stimulated with PR619 (30 μM during normoxia and hypoxia before the sample was harvested at indicated time points. The figure shows representative WB of IL-32 protein levels of n = 3 independent experiments. (B) JJN3 cells were incubated overnight in hypoxia before they were moved to normoxia for 4 h with and without PR619 stimulation. Cells were harvested, and lysates were processed in the presence of a NEM-DUB inhibitor. Ubiqutinylated and nonubiqutinylated 27 kDA IL-32 proteins were assessed by WB. (C) JJN3 cells were stimulated with a panel of DUB inhibitors (see Supplementary Table S1 for concentrations) for 4 h, and IL-32 protein levels were analyzed by WB. Shown here is the representative WB of n = 3 independent experiments. (D) Human primary T cells isolated from healthy blood donors were treated with CHX (5 µg/ml), MG132 (20 µM), and PR619 (30 µM) and harvested at the indicated time points. Shown here is the representative WB from experiments with n = 3 donors. (E) Human primary T cells isolated from healthy blood donors were cultured overnight in hypoxia before IL-32 protein levels were assessed by WB. A representative WB from experiments with three different donors is shown here. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

IL-32 has a high protein turnover. (A) JJN-3 cells were treated with CHX and harvested at the indicated time points. IL-32 protein levels were analyzed by WB. (B) Kinetics of IL-32 degradation in JJN3- cells. IL-32 protein signal intensity was quantified and normalized to loading control in n = 6 CHX chase experiments. The mean ±SEM is shown here. (C) JJN-3 cells were treated with 5 μg/ml CHX and 20 μM MG132 alone and in combination and harvested at the indicated time points. The figure shows one representative WB from n = 3 independent experiments. (D) Signal intensities of IL-32 and beta -actin were quantified from n = 3 independent experiments performed as in (C), and the values from treated samples at each time point were normalized relative to the control sample. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

IL-32 protein half-life is regulated by the oxygen sensor ADO. (A) JJN-3 cells were transfected with ADO- and nontargeting Ctrl siRNA. After 24 h, the cells were seeded and cultured overnight in normoxia or hypoxia before being treated with 5 μg/ml CHX and the IL-32 CHX chase assay in normoxia and hypoxia. One representative WB of IL-32 and ADO siRNA-treated cells of n = 5 independent experiments is shown. (B) JJN-3 cells were transfected with ADO and nontargeting Ctrl siRNA. After being transfected for 24 h, the cells were cultured overnight in hypoxia before being treated with 5 µg/ml CHX and reoxygenized in normoxic culture conditions. Cells were harvested at indicated time points. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

IL-32 is stabilized by deubiquitinases. (A) JJN3 cells were stimulated with PR619 (30 μM during normoxia and hypoxia before the sample was harvested at indicated time points. The figure shows representative WB of IL-32 protein levels of n = 3 independent experiments. (B) JJN3 cells were incubated overnight in hypoxia before they were moved to normoxia for 4 h with and without PR619 stimulation. Cells were harvested, and lysates were processed in the presence of a NEM-DUB inhibitor. Ubiqutinylated and nonubiqutinylated 27 kDA IL-32 proteins were assessed by WB. (C) JJN3 cells were stimulated with a panel of DUB inhibitors (see Supplementary Table S1 for concentrations) for 4 h, and IL-32 protein levels were analyzed by WB. Shown here is the representative WB of n = 3 independent experiments. (D) Human primary T cells isolated from healthy blood donors were treated with CHX (5 µg/ml), MG132 (20 µM), and PR619 (30 µM) and harvested at the indicated time points. Shown here is the representative WB from experiments with n = 3 donors. (E) Human primary T cells isolated from healthy blood donors were cultured overnight in hypoxia before IL-32 protein levels were assessed by WB. A representative WB from experiments with three different donors is shown here. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

IL-32 has a high protein turnover. (A) JJN-3 cells were treated with CHX and harvested at the indicated time points. IL-32 protein levels were analyzed by WB. (B) Kinetics of IL-32 degradation in JJN3- cells. IL-32 protein signal intensity was quantified and normalized to loading control in n = 6 CHX chase experiments. The mean ±SEM is shown here. (C) JJN-3 cells were treated with 5 μg/ml CHX and 20 μM MG132 alone and in combination and harvested at the indicated time points. The figure shows one representative WB from n = 3 independent experiments. (D) Signal intensities of IL-32 and beta -actin were quantified from n = 3 independent experiments performed as in (C), and the values from treated samples at each time point were normalized relative to the control sample. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Human IL-32 by Western Blot

Detection of Human IL-32 by Western Blot

IL-32 is degraded through the ubiquitin-proteasome pathway. (A, B) JJN3 cells were treated with 20 µM MG-132 and harvested at the indicated time points. IL-32 protein levels were analyzed by (A) Western blotting, and (B) IL-32 mRNA was assessed by qPCR using GAPDH as housekeeping gene. The bars show the mean RQ of IL-32 ± SD. (C) Confocal images of JJN3 cells treated for 4 h with 100 nM carfilzomib and stained with IL-32 antibody (green) and Hoechst (blue). (D) JJN3 cells were transfected with HA-ubiquitin plasmid and incubated in hypoxia overnight before the cells were harvested and IL-32 immunoprecipitation was performed. Protein levels of HA-ubiquitin, IL-32, and GAPDH loading control were evaluated on WB. Total lysate and IP samples from the same membrane are shown with different brightness/contrast. (E) JJN3 cells were incubated overnight in hypoxia before they were stimulated with MG-132 for 4 h and harvested for TUBE assay of ubiquitinylated proteins. The presence of IL-32 and ubiquitin protein in TUBE pulldown was assessed by WB. DUB treatment for reversal of polyubiqutinylation was included to validate ubiquitin/TUBE pulldown. Total lysate and TUBE samples from the same membrane are shown with different brightness/contrast. (F) JJN3 cells were stimulated with 2 μM TAK234 before the cells were harvested, and IL-32 levels were analyzed by WB. (A–F) One representative experiment out of three is shown. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

IL-32 has a high protein turnover. (A) JJN-3 cells were treated with CHX and harvested at the indicated time points. IL-32 protein levels were analyzed by WB. (B) Kinetics of IL-32 degradation in JJN3- cells. IL-32 protein signal intensity was quantified and normalized to loading control in n = 6 CHX chase experiments. The mean ±SEM is shown here. (C) JJN-3 cells were treated with 5 μg/ml CHX and 20 μM MG132 alone and in combination and harvested at the indicated time points. The figure shows one representative WB from n = 3 independent experiments. (D) Signal intensities of IL-32 and beta -actin were quantified from n = 3 independent experiments performed as in (C), and the values from treated samples at each time point were normalized relative to the control sample. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Human IL-32 by Western Blot

Detection of Human IL-32 by Western Blot

IL-32 is degraded through the ubiquitin-proteasome pathway. (A, B) JJN3 cells were treated with 20 µM MG-132 and harvested at the indicated time points. IL-32 protein levels were analyzed by (A) Western blotting, and (B) IL-32 mRNA was assessed by qPCR using GAPDH as housekeeping gene. The bars show the mean RQ of IL-32 ± SD. (C) Confocal images of JJN3 cells treated for 4 h with 100 nM carfilzomib and stained with IL-32 antibody (green) and Hoechst (blue). (D) JJN3 cells were transfected with HA-ubiquitin plasmid and incubated in hypoxia overnight before the cells were harvested and IL-32 immunoprecipitation was performed. Protein levels of HA-ubiquitin, IL-32, and GAPDH loading control were evaluated on WB. Total lysate and IP samples from the same membrane are shown with different brightness/contrast. (E) JJN3 cells were incubated overnight in hypoxia before they were stimulated with MG-132 for 4 h and harvested for TUBE assay of ubiquitinylated proteins. The presence of IL-32 and ubiquitin protein in TUBE pulldown was assessed by WB. DUB treatment for reversal of polyubiqutinylation was included to validate ubiquitin/TUBE pulldown. Total lysate and TUBE samples from the same membrane are shown with different brightness/contrast. (F) JJN3 cells were stimulated with 2 μM TAK234 before the cells were harvested, and IL-32 levels were analyzed by WB. (A–F) One representative experiment out of three is shown. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

TLR-induced NF kappa B signaling promotes IL-32 expression in MM cells. (A) RPMI-8226 cells were stimulated with TLR agonists (for concentrations, see methods) for 4 and 24 hours and IL-32 mRNA expression was assessed by qPCR. The figure shows mean ± SEM of 3 independent experiments. (B) RPMI-8226 cells were stimulated with TLR agonists for 4 and 24 hours and IL-32 protein expression was evaluated by western blot. The figure shows representative western blot of 3 independent experiments. (C) RPMI-8226 cells were harvested at different time-points following LPS stimulation (0.1 µg/mL) and IL-32 mRNA expression was analyzed by qPCR (mean ± SD) and (D) IL-32 protein expression by western blot (E) RPMI-8226 TLR4 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. Figure shows representative western blot (n=3) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (F) RPMI-8226 TLR9 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. The figure shows representative western blot (n=2) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (G) RPMI-8226 cells were stimulated with LPS (0.1 µg/mL) and NG25 (2 µM) or IKK VII (10 µM) for 4 hours. IL-32 mRNA expression (mean ± SEM, n=3) was assessed by qPCR. (H) RPMI-8226 cells were stimulated with LPS, NG25 and IKK VII (concentrations as above) for 4 hours. The figure shows representative western blot (n=3) of IL-32 protein expression. P-values in (A) and (G) are calculated by one-way ANOVA with Dunnett´s multiple comparison test. *p≤ 0.05, **p ≤ 0.001, ****p ≤ 0.0001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36875074), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of Human IL-32 by Western Blot

Detection of Human IL-32 by Western Blot

IL-32 is degraded through the ubiquitin-proteasome pathway. (A, B) JJN3 cells were treated with 20 µM MG-132 and harvested at the indicated time points. IL-32 protein levels were analyzed by (A) Western blotting, and (B) IL-32 mRNA was assessed by qPCR using GAPDH as housekeeping gene. The bars show the mean RQ of IL-32 ± SD. (C) Confocal images of JJN3 cells treated for 4 h with 100 nM carfilzomib and stained with IL-32 antibody (green) and Hoechst (blue). (D) JJN3 cells were transfected with HA-ubiquitin plasmid and incubated in hypoxia overnight before the cells were harvested and IL-32 immunoprecipitation was performed. Protein levels of HA-ubiquitin, IL-32, and GAPDH loading control were evaluated on WB. Total lysate and IP samples from the same membrane are shown with different brightness/contrast. (E) JJN3 cells were incubated overnight in hypoxia before they were stimulated with MG-132 for 4 h and harvested for TUBE assay of ubiquitinylated proteins. The presence of IL-32 and ubiquitin protein in TUBE pulldown was assessed by WB. DUB treatment for reversal of polyubiqutinylation was included to validate ubiquitin/TUBE pulldown. Total lysate and TUBE samples from the same membrane are shown with different brightness/contrast. (F) JJN3 cells were stimulated with 2 μM TAK234 before the cells were harvested, and IL-32 levels were analyzed by WB. (A–F) One representative experiment out of three is shown. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

IL-32 is stabilized by deubiquitinases. (A) JJN3 cells were stimulated with PR619 (30 μM during normoxia and hypoxia before the sample was harvested at indicated time points. The figure shows representative WB of IL-32 protein levels of n = 3 independent experiments. (B) JJN3 cells were incubated overnight in hypoxia before they were moved to normoxia for 4 h with and without PR619 stimulation. Cells were harvested, and lysates were processed in the presence of a NEM-DUB inhibitor. Ubiqutinylated and nonubiqutinylated 27 kDA IL-32 proteins were assessed by WB. (C) JJN3 cells were stimulated with a panel of DUB inhibitors (see Supplementary Table S1 for concentrations) for 4 h, and IL-32 protein levels were analyzed by WB. Shown here is the representative WB of n = 3 independent experiments. (D) Human primary T cells isolated from healthy blood donors were treated with CHX (5 µg/ml), MG132 (20 µM), and PR619 (30 µM) and harvested at the indicated time points. Shown here is the representative WB from experiments with n = 3 donors. (E) Human primary T cells isolated from healthy blood donors were cultured overnight in hypoxia before IL-32 protein levels were assessed by WB. A representative WB from experiments with three different donors is shown here. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

IL-32 protein half-life is regulated by the oxygen sensor ADO. (A) JJN-3 cells were transfected with ADO- and nontargeting Ctrl siRNA. After 24 h, the cells were seeded and cultured overnight in normoxia or hypoxia before being treated with 5 μg/ml CHX and the IL-32 CHX chase assay in normoxia and hypoxia. One representative WB of IL-32 and ADO siRNA-treated cells of n = 5 independent experiments is shown. (B) JJN-3 cells were transfected with ADO and nontargeting Ctrl siRNA. After being transfected for 24 h, the cells were cultured overnight in hypoxia before being treated with 5 µg/ml CHX and reoxygenized in normoxic culture conditions. Cells were harvested at indicated time points. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

TLR-induced NF kappa B signaling promotes IL-32 expression in MM cells. (A) RPMI-8226 cells were stimulated with TLR agonists (for concentrations, see methods) for 4 and 24 hours and IL-32 mRNA expression was assessed by qPCR. The figure shows mean ± SEM of 3 independent experiments. (B) RPMI-8226 cells were stimulated with TLR agonists for 4 and 24 hours and IL-32 protein expression was evaluated by western blot. The figure shows representative western blot of 3 independent experiments. (C) RPMI-8226 cells were harvested at different time-points following LPS stimulation (0.1 µg/mL) and IL-32 mRNA expression was analyzed by qPCR (mean ± SD) and (D) IL-32 protein expression by western blot (E) RPMI-8226 TLR4 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. Figure shows representative western blot (n=3) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (F) RPMI-8226 TLR9 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. The figure shows representative western blot (n=2) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (G) RPMI-8226 cells were stimulated with LPS (0.1 µg/mL) and NG25 (2 µM) or IKK VII (10 µM) for 4 hours. IL-32 mRNA expression (mean ± SEM, n=3) was assessed by qPCR. (H) RPMI-8226 cells were stimulated with LPS, NG25 and IKK VII (concentrations as above) for 4 hours. The figure shows representative western blot (n=3) of IL-32 protein expression. P-values in (A) and (G) are calculated by one-way ANOVA with Dunnett´s multiple comparison test. *p≤ 0.05, **p ≤ 0.001, ****p ≤ 0.0001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36875074), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

IL-32 is stabilized by deubiquitinases. (A) JJN3 cells were stimulated with PR619 (30 μM during normoxia and hypoxia before the sample was harvested at indicated time points. The figure shows representative WB of IL-32 protein levels of n = 3 independent experiments. (B) JJN3 cells were incubated overnight in hypoxia before they were moved to normoxia for 4 h with and without PR619 stimulation. Cells were harvested, and lysates were processed in the presence of a NEM-DUB inhibitor. Ubiqutinylated and nonubiqutinylated 27 kDA IL-32 proteins were assessed by WB. (C) JJN3 cells were stimulated with a panel of DUB inhibitors (see Supplementary Table S1 for concentrations) for 4 h, and IL-32 protein levels were analyzed by WB. Shown here is the representative WB of n = 3 independent experiments. (D) Human primary T cells isolated from healthy blood donors were treated with CHX (5 µg/ml), MG132 (20 µM), and PR619 (30 µM) and harvested at the indicated time points. Shown here is the representative WB from experiments with n = 3 donors. (E) Human primary T cells isolated from healthy blood donors were cultured overnight in hypoxia before IL-32 protein levels were assessed by WB. A representative WB from experiments with three different donors is shown here. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.
Detection of IL-32 by Western Blot

Detection of IL-32 by Western Blot

IL-32 is stabilized by deubiquitinases. (A) JJN3 cells were stimulated with PR619 (30 μM during normoxia and hypoxia before the sample was harvested at indicated time points. The figure shows representative WB of IL-32 protein levels of n = 3 independent experiments. (B) JJN3 cells were incubated overnight in hypoxia before they were moved to normoxia for 4 h with and without PR619 stimulation. Cells were harvested, and lysates were processed in the presence of a NEM-DUB inhibitor. Ubiqutinylated and nonubiqutinylated 27 kDA IL-32 proteins were assessed by WB. (C) JJN3 cells were stimulated with a panel of DUB inhibitors (see Supplementary Table S1 for concentrations) for 4 h, and IL-32 protein levels were analyzed by WB. Shown here is the representative WB of n = 3 independent experiments. (D) Human primary T cells isolated from healthy blood donors were treated with CHX (5 µg/ml), MG132 (20 µM), and PR619 (30 µM) and harvested at the indicated time points. Shown here is the representative WB from experiments with n = 3 donors. (E) Human primary T cells isolated from healthy blood donors were cultured overnight in hypoxia before IL-32 protein levels were assessed by WB. A representative WB from experiments with three different donors is shown here. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Human IL-32 Antibody

Application
Recommended Usage

Western Blot

0.1 µg/mL
Sample:

Recombinant Human IL‑32 alpha

Recombinant Human IL-32 beta

Recombinant Human IL-32 gamma (Catalog # 4690-IL/CF)

Reviewed Applications

Read 2 reviews rated 3 using AF3040 in the following applications:

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: IL-32

Interleukin 32 (IL-32) is an N-glycosylated cytokine that is upregulated by inflammatory stimulation in monocytes, NK cells, epithelial cells, and pancreatic myofibroblasts (1-5). It cooperates with these stimuli to promote the expression of other proinflammatory molecules such as TNF-alpha, IL-6, IL-1 beta, IL-1 alpha, and CXCL8/IL‑8 (5-7). The longest of several IL-32 splicing variants is the 20-25 kDa gamma isoform which is also known as natural killer cell transcript 4 (NK4) (8, 9). The alpha isoform (IL-32 alpha ) lacks a portion of the putative signal peptide as well as 57 aa from the C-terminal region. IL-32 alpha is less potent than IL-32 beta, gamma, or delta at inducing the expression of proinflammatory molecules in peripheral blood mononuclear cells (PBMC) (8, 10). Neutrophil-derived Proteinase 3 (PR3) cleaves IL-32 alpha between Thr57 and Val58, a cleavage site that is retained in other IL-32 isoforms (11). The N-terminal fragment of PR3-cleaved IL-32 alpha shows increased potency at inducing CXCL2/MIP-2 and CXCL8 expression in PBMC relative to uncleaved IL-32 alpha (11, 12). IL-32 is highly expressed by colonic epithelial cells in inflammatory bowel disease and Crohn’s disease, rheumatoid arthritis synovium, and ductal epithelial cells in chronic pancreatitis and pancreatic cancer (5, 13-15). IL-32 inhibits HIV-1 replication in vitro, and it is elevated in the serum of HIV-1 patients (16, 17).

References

  1. Netea, M.G. et al. (2006) PloS Med. 3:e277.
  2. Nold-Petry, C.A. et al. (2009) Proc. Natl. Acad. Sci. USA 106:3883.
  3. Li, W. et al. (2009) Eur. J. Immunol. 39:1019.
  4. Nishida, A. et al. (2008) Am. J. Physiol. Gastrointest. Liver Physiol. 294:G831.
  5. Shoda, H. et al. (2006) Arthritis Res. Ther. 8:R166.
  6. Netea, M.G. et al. (2005) Proc. Natl. Acad. Sci. USA 102:16309.
  7. Hong, J. et al. (2010) Cytokine 49:171.
  8. Kim, S-H. et al. (2005) Immunity 22:131.
  9. Dahl, C.A. et al. (1992) J. Immunol. 148:597.
  10. Choi, J-D. et al. (2009) Immunology 126:535.
  11. Novick, D. et al. (2006) Proc. Natl. Acad. Sci. USA 103:3316.
  12. Kim, S. et al. (2008) BMB Rep. 41:814.
  13. Shioya, M. et al. (2007) Clin. Exp. Immunol. 149:480.
  14. Joosten, L.A.B. et al. (2006) Proc. Natl. Acad. Sci. USA 103:3298.
  15. Nishida, A. et al. (2009) J. Biol. Chem. 284:17868.
  16. Rasool, S.T. et al. (2008) Immunol. Lett. 117:161.
  17. Nold, M.F. et al. (2008) J. Immunol. 181:557.

Long Name

Interleukin 32

Alternate Names

IL32, NK4, TAIF

Entrez Gene IDs

9235 (Human)

Gene Symbol

IL32

UniProt

NP_001012651

Additional IL-32 Products

Product Documents for Human IL-32 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Human IL-32 Antibody

For research use only

Citations for Human IL-32 Antibody

Customer Reviews for Human IL-32 Antibody (2)

3 out of 5
2 Customer Ratings
5 Stars
50%
4 Stars
0%
3 Stars
0%
2 Stars
0%
1 Stars
50%

Have you used Human IL-32 Antibody?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Customer Images

Showing  1 - 2 of 2 reviews Showing All
Filter By:
Clear Filters X
  • Human IL-32 Antibody
    Name: Anonymous
    Application: Immunocytochemistry/Immunofluorescence
    Sample Tested: Adult lung
    Species: Human
    Verified Customer | Posted 03/08/2019
    Did not work with human lung sections without retreival or with citrate retreival - IgG was used as control.
    Human IL-32 Antibody AF3040
    Bio-Techne Response
    Thank you for reviewing our product. We are sorry to hear that this antibody did not perform as expected. We have been in touch with the customer to resolve this issue according to our Product Guarantee and to the customer’s satisfaction.
  • Name: Anonymous
    Application: Western Blot
    Sample Tested: See PMID 22890997
    Species: Human
    Verified Customer | Posted 01/07/2015

There are no reviews that match your criteria.

Showing  1 - 2 of 2 reviews Showing All

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies